In tumors, the expression of SNAI1 and SNAI2 leads to decreased E-cadherin levels and enhanced tumor cell metastasis, and it is associated with the poor prognosis of breast cancer patients (Blanco et al. 2002; Tran et al. 2014). This evidence concerns the gene SNAI2 and breast cancer.